RE MASTINIB SHOWS PROMISE IN STUDY FOR TREATING PMS

A board to discuss future MS therapies in early stage (Phase I or II) trials.
Post Reply
User avatar
seeva
Family Elder
Posts: 511
Joined: Sun Jan 20, 2008 3:00 pm
Location: SYDNEY
Contact:

RE MASTINIB SHOWS PROMISE IN STUDY FOR TREATING PMS

Post by seeva »

HI FRIENDS PLEASE READ
http://multiplesclerosisnewstoday.com/2 ... -patients/
regards
seeva
User avatar
frodo
Family Elder
Posts: 1749
Joined: Wed Dec 02, 2009 3:00 pm
Contact:

Re: RE MASTINIB SHOWS PROMISE IN STUDY FOR TREATING PMS

Post by frodo »

seeva wrote:HI FRIENDS PLEASE READ
http://multiplesclerosisnewstoday.com/2 ... -patients/
regards
seeva
Thanks. Very interesting.
User avatar
zen2010
Family Elder
Posts: 249
Joined: Mon Mar 15, 2010 3:00 pm
Location: Villeurbanne, France

Re: RE MASTINIB SHOWS PROMISE IN STUDY FOR TREATING PMS

Post by zen2010 »

Thks Seeva,

Problem is we don't know what "non futile" means.
That would be great if they could speak with data...
User avatar
NHE
Volunteer Moderator
Posts: 6235
Joined: Sat Nov 20, 2004 3:00 pm
Contact:

Re: RE MASTINIB SHOWS PROMISE IN STUDY FOR TREATING PMS

Post by NHE »

zen2010 wrote: Mon Aug 22, 2016 4:45 am Problem is we don't know what "non futile" means.
That would be great if they could speak with data...
Non-futile means that halfway through the trial there was sufficient efficacy seen that the researchers were justified in continuing the trial. A futility analysis is important as it prevents the research group from wasting money on a potential treatment that shows no demonstrable effect.
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Drug Pipeline”